全文获取类型
收费全文 | 2387篇 |
免费 | 234篇 |
国内免费 | 41篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 35篇 |
妇产科学 | 24篇 |
基础医学 | 261篇 |
口腔科学 | 20篇 |
临床医学 | 359篇 |
内科学 | 81篇 |
皮肤病学 | 10篇 |
神经病学 | 381篇 |
特种医学 | 26篇 |
外科学 | 69篇 |
综合类 | 433篇 |
预防医学 | 327篇 |
眼科学 | 11篇 |
药学 | 192篇 |
中国医学 | 404篇 |
肿瘤学 | 24篇 |
出版年
2024年 | 7篇 |
2023年 | 61篇 |
2022年 | 80篇 |
2021年 | 125篇 |
2020年 | 94篇 |
2019年 | 95篇 |
2018年 | 82篇 |
2017年 | 95篇 |
2016年 | 85篇 |
2015年 | 74篇 |
2014年 | 174篇 |
2013年 | 248篇 |
2012年 | 147篇 |
2011年 | 205篇 |
2010年 | 140篇 |
2009年 | 134篇 |
2008年 | 152篇 |
2007年 | 128篇 |
2006年 | 99篇 |
2005年 | 76篇 |
2004年 | 63篇 |
2003年 | 61篇 |
2002年 | 50篇 |
2001年 | 24篇 |
2000年 | 32篇 |
1999年 | 23篇 |
1998年 | 15篇 |
1997年 | 18篇 |
1996年 | 8篇 |
1995年 | 7篇 |
1994年 | 6篇 |
1993年 | 5篇 |
1992年 | 7篇 |
1991年 | 7篇 |
1990年 | 5篇 |
1989年 | 4篇 |
1988年 | 5篇 |
1987年 | 3篇 |
1986年 | 2篇 |
1984年 | 1篇 |
1983年 | 2篇 |
1982年 | 2篇 |
1981年 | 3篇 |
1980年 | 1篇 |
1979年 | 3篇 |
1976年 | 1篇 |
1972年 | 2篇 |
1966年 | 1篇 |
排序方式: 共有2662条查询结果,搜索用时 0 毫秒
91.
92.
93.
目的 观察增液八珍汤治疗习惯性便秘的临床疗效.方法 将100例习惯性便秘的患者随机分成治疗组和对照组,各50例.治疗组口服增液八珍汤(党参、白术、茯苓、当归等,1剂/d,早晚分服)治疗;对照组口服西沙比利(10 mg/次,3次/d,饭前口服),疗程1个月.分别检测治疗前后受试者血清中胃泌素(GAS)、P物质(SP)、生长抑素(SS)的含量.结果 治疗组治愈率58%,总有效率为98%,复发率10.3%;对照组治愈率24%,总有效率为72%,复发率33.3%.2组治愈率、总有效率比较,差异有统计学意义(P<0.01,P<0.05);治疗前后2组受试者血清中胃泌素(GAS)、P物质(SP)、生长抑素(SS)含量均有明显变化,治疗组变化明显优于对照组(P<0.05).结论 增液八珍汤治疗习惯性便秘复发率低,无毒副作用,并能改善血清中GAS、SP、SS含量. 相似文献
94.
95.
Background
Real time 1:1 videoconferencing (VC) has the potential to play an important role in the management of orthopaedic pathologies. Despite positive reporting of telemedicine studies uptake in clinical practice remains low. Acceptability to patients is an important element of system take-up in telemedicine and a focus towards qualitative methodology may explore the underlying reasons behind its acceptability. In this paper we have systematically reviewed qualitative studies that include evidence about patient responses to VC services in an orthopaedic setting.Objectives
To determine whether real time 1:1 videoconferencing is acceptable to patients in an orthopaedic setting.Data sources
MEDLINE, AMED, PsychINFO, CINAHL, SCOPUS, Cochrane Database, Evidence Search and Open Grey were searched with forwards and backwards reference screening of eligible papers.Eligibility criteria
Qualitative studies exploring the acceptability of VC in an orthopaedic setting were included.Study appraisal and synthesis methods
Studies were appraised using the CASP tool. A Directed Content Framework Analysis was conducted using Normalisation Process Theory.Results
Four studies were included for review. The themes for the four studies did not overlap and did not report clinician acceptability of VC. The Directed Content Analysis of these papers using Normalisation Process Theory highlighted factors which contribute towards its acceptability.Conclusions
All studies concluded that the use of VC was acceptable. Further qualitative research exploring both patient and clinician acceptability is required utilising a theoretical framework to allow for repeatability and generalisability.Systematic Review Registration Number: PROSPERO CRD42015024944. 相似文献
96.
Blathin Casey Susan Coote Sara Hayes Stephen Gallagher 《Archives of physical medicine and rehabilitation》2018,99(10):2059-2075
Objectives
To (1) systematically review the literature on behavioral interventions for people with multiple sclerosis (MS) that aim to change physical activity (PA) behavior; and (2) explore whether these interventions are clinically effective in improving PA, are theory based, and use established behavior change techniques (BCTs).Data Sources
A systematic electronic search was conducted on databases EBSCO (including AMED, Biomedical Reference Collection: Expanded, CINHAL, MEDLINE, PsycArticles, PsycInfo), PubMed, EMBASE, and Web of Science from April 2017 to May 2017.Study Selection
Studies were included if (1) the interventions aimed to change PA behavior among people with MS; (2) PA was recognized as a primary outcome measure; and (3) they had a randomized controlled trial (RCT) design.Data Extraction
The resulting behavioral interventions were coded using the Theory Coding Scheme and the CALO-RE taxonomy to assess theory base and BCTs. A meta-analysis was conducted to assess effectiveness.Data Synthesis
Fourteen RCTs were included. Combined, there was a significant (P=.0003; d=1.00; 95% confidence interval, .46–1.53) short-term change in self-report PA behavior for studies with nonactive control groups. There was no change in objective or long-term PA. Studies failed to discuss results in relation to theory and did not attempt to refine theory. Fifty percent of BCTs within the CALO-RE were used, with BCTs of “goal-setting” and “action-planning” being the most frequently used.Conclusions
Current evidence supports the efficacy of PA intervention on subjective but not objective outcomes. However, conclusions from this review should be interpreted with caution because of the small number of studies included and small sample size. Further, while using theory in intervention design, interventions in this review have not reported the refining of theory. Exploration of the use of additional BCTs to change PA behavior is also required within future interventions. 相似文献97.
Translational Mobilisation Theory (TMT) is a generic sociological theory that explains how emergent projects of collective action are progressed in complex organisational contexts. Grounded in a substantial programme of research on healthcare work, it has value for understanding the organisational component of the nursing role for educational, practice and research purposes. This paper introduces Translational Mobilisation Theory, outlines its core components, and considers its application to nursing using ethnographic research on the organising work of nurses as an empirical reference. Organising work is a neglected element of the nursing function and lacks theoretical foundations. As the complexity and intensity of healthcare continues to accelerate this is an important gap in existing frameworks of understanding. 相似文献
98.
王伟 《中华医学图书情报杂志》2015,24(10):1-4
[]本硕博连读研究生培养模式旨在培养具有原创精神和能力的研究型人才。本文从多元智力理论出发,从理论层面对本硕博连读培养模式进行阐述;结合研究生教育改革实践,从选拔标准、培养模式、过程管理、质量监控、分流淘汰机制、论文答辩以及学术成果要求等几个方面对医学信息学本硕博连读培养中的关键环节进行了分析。 相似文献
99.
:Since July 1984, eight patients with advanced hairy cell leukemia have received treatment with recombinant alpha A interferon. At commencement of interferon, seven patients had progressive cytopenia, and one was in leukemic phase (>20times109/L circulating hairy cells). All patients had had previous splenectomy. Interferon was administered subcutaneously. The initial dose was 3times106 U/day, continued until peripheral counts stabilised. Subsequently, patients received 6times106 U/day, 9times106 U/day, and finally 12 times 106 U/day. The dose increases proceeded every 8–12 weeks, as tolerated. Seven patients had an objective response. There were four complete remissions, two partial remissions, and one minor response. Complete remission was documented only in patients on at least 6 times 106 U/day for 12 weeks. The median time to complete remission was 40 weeks (range 35–53). Normalisation of peripheral blood counts preceded histologic marrow improvement. The median times for response (platelets ≤ 100 times 109L, hemaglobin > 12 gm/dL, neutrophils < 1.5 times 109/L), were six to eight and 17 weeks, respectively. Toxicity included myelosuppression during the first four weeks of therapy. With increasing doses of interferon, myelosuppression did not recur. A transient, mild, flu-like syndrome affected all patients. Two patients developed asymptomatic transaminitis at doses >6 times 106 U/day. This resolved with dose reduction. In one case impotence was reported during the first four weeks of each interferon level. One patient discontinued after two weeks due to an exacerbation of systemic vasculitis. The median duration of treatment for the seven responding patients is 78 weeks (range 30–156). All remain on interferon without disease progression. This report confirms a high remission rate, which may reflect a dose-response phenomenon for long-term treatment with alpha interferon in hairy cell leukemia. (Aust NZ J Med 1988; 18: 557–562). 相似文献
100.